• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有软组织肉瘤患者应用的灵活风险比治愈模型。

A flexible-hazards cure model with application to patients with soft tissue sarcoma.

机构信息

Department of Biostatistics and Data Science, The University of Texas Health Science Center at Houston, Houston, Texas, USA.

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

出版信息

Stat Med. 2022 Dec 20;41(29):5698-5714. doi: 10.1002/sim.9588. Epub 2022 Sep 27.

DOI:10.1002/sim.9588
PMID:36165535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9691595/
Abstract

In medical research, it is often of great interest to have an accurate estimation of cure rates by different treatment options and for different patient groups. If the follow-up time is sufficiently long and the sample size is large, the proportion of cured patients will make the Kaplan-Meier estimator of survival function have a flat plateau at its tail, whose value indicates the overall cure rate. However, it may be difficult to estimate and compare the cure rates for all the subsets of interest in this way, due to the limit of sample sizes and curse of dimensionality. In the current literature, most regression models for estimating cure rates assume proportional hazards (PH) between different subgroups. It turns out that the estimation of cure rates for subgroups is highly sensitive to this assumption, so more flexible models are needed, especially when this PH assumption is clearly violated. We propose a new cure model to simultaneously incorporate both PH and non-PH scenarios for different covariates. We develop a stable and easily implementable iterative procedure for parameter estimation through maximization of the nonparametric likelihood function. The covariance matrix is estimated by adding perturbation weights to the estimation procedure. In simulation studies, the proposed method provides unbiased estimation for the regression coefficients, survival curves, and cure rates given covariates, while existing models are biased. Our model is applied to a study of stage III soft tissue sarcoma and provides trustworthy estimation of cure rates for different treatment and demographic groups.

摘要

在医学研究中,对于不同的治疗方案和不同的患者群体,准确估计治愈率通常非常重要。如果随访时间足够长且样本量足够大,则治愈患者的比例将使生存函数的 Kaplan-Meier 估计器在尾部出现平坦的高原,其值表示总体治愈率。然而,由于样本量的限制和维度的诅咒,可能难以以这种方式估计和比较所有感兴趣的亚组的治愈率。在当前的文献中,大多数用于估计治愈率的回归模型都假设不同亚组之间存在比例风险 (PH)。事实证明,亚组治愈率的估计对该假设非常敏感,因此需要更灵活的模型,特别是当明显违反此 PH 假设时。我们提出了一种新的治愈率模型,用于同时为不同协变量结合 PH 和非 PH 情况。我们通过最大化非参数似然函数来开发一种稳定且易于实施的参数估计迭代过程。通过向估计过程添加扰动权重来估计协方差矩阵。在模拟研究中,所提出的方法为给定协变量的回归系数、生存曲线和治愈率提供了无偏估计,而现有模型则存在偏差。我们的模型应用于 III 期软组织肉瘤的研究,并为不同治疗和人口统计学组提供了可靠的治愈率估计。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44d9/9691595/b84300bb4198/nihms-1837273-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44d9/9691595/76a726a0964d/nihms-1837273-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44d9/9691595/172971559766/nihms-1837273-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44d9/9691595/7cda7d124005/nihms-1837273-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44d9/9691595/3b1f5c0d6119/nihms-1837273-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44d9/9691595/b84300bb4198/nihms-1837273-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44d9/9691595/76a726a0964d/nihms-1837273-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44d9/9691595/172971559766/nihms-1837273-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44d9/9691595/7cda7d124005/nihms-1837273-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44d9/9691595/3b1f5c0d6119/nihms-1837273-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44d9/9691595/b84300bb4198/nihms-1837273-f0005.jpg

相似文献

1
A flexible-hazards cure model with application to patients with soft tissue sarcoma.具有软组织肉瘤患者应用的灵活风险比治愈模型。
Stat Med. 2022 Dec 20;41(29):5698-5714. doi: 10.1002/sim.9588. Epub 2022 Sep 27.
2
Semiparametric accelerated failure time cure rate mixture models with competing risks.具有竞争风险的半参数加速失效时间治愈率混合模型
Stat Med. 2018 Jan 15;37(1):48-59. doi: 10.1002/sim.7508. Epub 2017 Oct 6.
3
A class of semiparametric transformation models for survival data with a cured proportion.一类具有治愈比例的生存数据半参数变换模型。
Lifetime Data Anal. 2014 Jul;20(3):369-86. doi: 10.1007/s10985-013-9268-2. Epub 2013 Jun 13.
4
The single-index/Cox mixture cure model.单指标/Cox混合治愈模型。
Biometrics. 2019 Jun;75(2):452-462. doi: 10.1111/biom.12999. Epub 2019 Mar 29.
5
A general class of semiparametric transformation frailty models for nonproportional hazards survival data.用于非比例风险生存数据的一类半参数变换脆弱模型。
Biometrics. 2012 Dec;68(4):1126-35. doi: 10.1111/j.1541-0420.2012.01784.x. Epub 2012 Sep 24.
6
Partly linear single-index cure models with a nonparametric incidence link function.部分线性单指标治愈模型与非参数发生率链接函数。
Stat Methods Med Res. 2024 Mar;33(3):498-514. doi: 10.1177/09622802241227960. Epub 2024 Feb 23.
7
A nonparametric mixture model for cure rate estimation.一种用于治愈率估计的非参数混合模型。
Biometrics. 2000 Mar;56(1):237-43. doi: 10.1111/j.0006-341x.2000.00237.x.
8
Proportional hazards under Conway-Maxwell-Poisson cure rate model and associated inference.康威 - 麦克斯韦 - 泊松治愈率模型下的比例风险及相关推断
Stat Methods Med Res. 2017 Oct;26(5):2055-2077. doi: 10.1177/0962280217708683. Epub 2017 May 19.
9
Defective 3-parameter Gompertz model with frailty term for estimating cure fraction in survival data.用于估计生存数据中治愈分数的具有脆弱项的缺陷三参数冈珀茨模型。
J Biopharm Stat. 2023 Jan 2;33(1):90-113. doi: 10.1080/10543406.2022.2080689. Epub 2022 Jun 7.
10
Comparison of methods for estimating the attributable risk in the context of survival analysis.生存分析背景下可归因风险估计方法的比较
BMC Med Res Methodol. 2017 Jan 23;17(1):10. doi: 10.1186/s12874-016-0285-1.

引用本文的文献

1
INDIVIDUAL DYNAMIC PREDICTION FOR CURE AND SURVIVAL BASED ON LONGITUDINAL BIOMARKERS.基于纵向生物标志物的治愈和生存个体动态预测
Ann Appl Stat. 2024 Dec;18(4):2796-2817. doi: 10.1214/24-aoas1906. Epub 2024 Oct 31.

本文引用的文献

1
Joint analysis of longitudinal measurements and survival times with a cure fraction based on partly linear mixed and semiparametric cure models.基于部分线性混合模型和半参数治愈模型对具有治愈比例的纵向测量值和生存时间进行联合分析。
Pharm Stat. 2021 Mar;20(2):362-374. doi: 10.1002/pst.2082. Epub 2020 Nov 22.
2
Joint longitudinal and time-to-event cure models for the assessment of being cured.用于评估治愈情况的联合纵向和时依治愈模型。
Stat Methods Med Res. 2020 Apr;29(4):1256-1270. doi: 10.1177/0962280219853599. Epub 2019 Jun 19.
3
Promotion time cure rate model with nonparametric form of covariate effects.
具有非参数协变量效应形式的促销时间治愈率模型。
Stat Med. 2018 May 10;37(10):1625-1635. doi: 10.1002/sim.7597. Epub 2018 Jan 17.
4
Inference in a survival cure model with mismeasured covariates using a simulation-extrapolation approach.使用模拟外推法对具有测量误差协变量的生存治愈模型进行推断。
Polit Anal. 2017 Mar 1;104(1):31-50. doi: 10.1093/biomet/asw054. Epub 2017 Jan 3.
5
Joint longitudinal and survival-cure models in tumour xenograft experiments.肿瘤异种移植实验中的联合纵向和生存-治愈模型
Stat Med. 2014 Aug 15;33(18):3229-40. doi: 10.1002/sim.6175. Epub 2014 Apr 20.
6
Joint Modeling of Longitudinal and Cure-survival Data.纵向数据与治愈生存数据的联合建模
J Stat Theory Pract. 2013 Apr 1;7(2):324-344. doi: 10.1080/15598608.2013.772036.
7
A New Semiparametric Estimation Method for Accelerated Hazards Mixture Cure Model.加速风险混合治愈模型的一种新的半参数估计方法
Comput Stat Data Anal. 2013 Mar;59:95-102. doi: 10.1016/j.csda.2012.09.017.
8
Three-component cure rate model for nonproportional hazards alternative in the design of randomized clinical trials.三组件非比例风险替代 cure 率模型在随机临床试验设计中的应用。
Clin Trials. 2012 Apr;9(2):155-63. doi: 10.1177/1740774512436614. Epub 2012 Feb 21.
9
Two-component mixture cure rate model with spline estimated nonparametric components.具有样条估计非参数分量的双组分混合物治愈率模型。
Biometrics. 2012 Sep;68(3):726-35. doi: 10.1111/j.1541-0420.2011.01715.x. Epub 2011 Dec 14.
10
Estimating Cure Rates From Survival Data: An Alternative to Two-Component Mixture Models.从生存数据估计治愈率:双组分混合模型的替代方法
J Am Stat Assoc. 2003 Dec 1;98(464):1063-1078. doi: 10.1198/01622145030000001007.